Inhibition of metabolic pathways can lead to a halt in energy production and synthesis of essential biomolecules. For instance, inhibitors of glycolysis or oxidative phosphorylation can drastically affect cell viability. This approach is often used to target rapidly growing cancer cells that have high metabolic demands.
